Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Randomized, Open Label Study to Assess the Effects of a Nasal Corticosteroid on the Pharmacokinetics, Safety, and Tolerability of PMI-150 (Intranasal Ketamine Hydrochloride) 30 mg


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00662883

Organisation Name: Javelin Pharmaceuticals

Overal Status: Completed

Start Date: November 2007

Last Update: April 22, 2008

Lead Sponsor: Javelin Pharmaceuticals

Brief Summary: To assess the effects of nasal corticosteroid treatment on the rate and extent of intranasal absorption of PMI-150 (intranasal ketamine HCl)

Conditions:
  • Healthy


Total execution time in seconds: 0.14764809608459